UBS AM’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

UBS AM’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-38,677	Closed	-$7.5M	–	2707
2015 Q2	$7.5M	Buy	38,677 +2,026	+6%	+$376K	0.01%	970
2015 Q1	$5.43M	Buy	36,651 +1,948	+6%	+$297K	0.01%	1029
2014 Q4	$5.41M	Buy	34,703 +37	+0.1%	+$5.33K	0.01%	1016
2014 Q3	$4.97M	Buy	34,666 +1,748	+5%	+$253K	﹤0.01%	1033
2014 Q2	$4.3M	Sell	32,918 -15,636	-32%	-$1.99M	﹤0.01%	1072
2014 Q1	$5.94M	Buy	48,554 +3,513	+8%	+$381K	0.01%	994
2013 Q4	$4.78M	Buy	45,041 +5,621	+14%	+$545K	0.01%	1017
2013 Q3	$4.42M	Buy	39,420 +2,970	+8%	+$337K	0.01%	1016
2013 Q2	$4.11M	Buy	+36,450	New	+$4.46M	0.01%	1005

Other funds holding SRGA

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Hillman Company Pittsburgh, Pennsylvania $257M AUM 26.39% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

TCM

Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

KIA

Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

UBS AM's SRGA Position: Q3 2015 in Review

UBS AM sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2015, closing a stake of 38,677 shares — an estimated $7.5M sold.

UBS AM first reported a position in SRGA in Q2 2013 and held it in 9 quarters. The position peaked at $7.5M in Q2 2015. 120 funds tracked by Wall St. Rank hold SRGA as of Q3 2015.

UBS AM reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
UBS AM sold 38,677 Surgalign Holdings, Inc. Common Stock shares in Q3 2015, an estimated $7.5M.
UBS AM first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 9 quarters.
UBS AM's Surgalign Holdings, Inc. Common Stock position peaked at $7.5M in Q2 2015.
120 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2015.

Based on UBS AM's 13F filing for Q3 2015, filed 29 Oct 2015.